US healthcare company Baxter welcomes Health Ministry initiative

Ivan Tomov, Country Managing Director of Baxter Romania & Bulgaria said today the recent initiative of the Ministry of Health on 40% budget increase for hemophilia and thalassemia treatments, and the introduction, for the first time, of the prophylactic treatment programs for children represent a great achievement, raising the quota from below one unit per capita to 1.5 unit.

The US-based healthcare company is the world market leader in the treatment of hemophilia patients, with a legacy built over 80 years.

“For each hemophilia patient we should have a personalized treatment, and here we can have a major contribution through our expertise and know-how for both physicians and authorities”, added Tomov.

He also announced that Baxter Romania’s office has become fully operational starting this July.

“We believe the moment we became operational is a favorable one, both in terms of economy and business environment,” he commented.

Read more about

Vodafone once again receives “Best in Test” certification for best mobile network in Romania

read more

Baxter products have been sold in Romania since 2003, through various distributors, with a turnover of seven million USD. For the year of 2014, Tomov estimates a turnover of over 10 million USD generated from the activities on the Romanian market and future investments of around 1 million USD.

Baxter has 61,500 employees worldwide, manufactures in 27 countries and sells them in more than 100.